- Home
- / Zosano Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Zosano Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.2
2022-08-02
Market Capitalization
$66 M
2022-08-02
CreditSafe Score
?
Score changed on Jun 28, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 47.4K | 15.3K | 33.3K | 32.6K | 35.5K | 160.4K | 87.4K | 34.3K |
| Operating expense total | 47.4K | 15.3K | 33.3K | 32.6K | 35.5K | 160.4K | 87.4K | 34.3K |
| EBIT | (47.4K) | (15.3K) | (33.3K) | (32.6K) | (35.5K) | (160.4K) | (87.4K) | (34.3K) |
| Pre tax profit | 87.4K | 34.3K | ||||||
| Net Income | (47.4K) | (15.3K) | (33.3K) | (32.6K) | (35.5K) | (160.4K) | (87.4K) | (34.3K) |